Kelly A. Cycon

GRP78/BiP/HSPA5/Dna K is a universal therapeutic target for human disease

Laurence Booth, Jane L. Roberts, Devin R. Cash et al. · Journal of Cellular Physiology · 2014 · 97 citations · Full text

Grp78/bip/hspa5/dna K, Immunology, Human Polymorphism +16

Histone deacetylase inhibitors activate <scp>CIITA</scp> and MHC class <scp>II</scp> antigen expression in diffuse large B‐cell lymphoma

Kelly A. Cycon, Kathleen M. Mulvaney, Lisa M. Rimsza et al. · Immunology · 2013 · 76 citations · Full text

Histone Modifications, Lymphoid Neoplasia, Hematological Malignancy +13

GRP78/Dna K Is a Target for Nexavar/Stivarga/Votrient in the Treatment of Human Malignancies, Viral Infections and Bacterial Diseases

Jane L. Roberts, Mehrad Tavallai, Aida Nourbakhsh et al. · Journal of Cellular Physiology · 2015 · 61 citations · Full text

Immunology, Pathology, Nucleic Acid Amplification Test +17

Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL)

Kelly A. Cycon, Lisa M. Rimsza, Shawn P. Murphy · Experimental Hematology · 2008 · 44 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Ciita Constitute +9

Differential contribution of TAP and tapasin to HLA class I antigen expression

Alan Belicha‐Villanueva, Sarah McEvoy, Kelly A. Cycon et al. · Immunology · 2008 · 21 citations · Full text